-
公开(公告)号:EP2721016A1
公开(公告)日:2014-04-23
申请号:EP12814591.9
申请日:2012-06-15
发明人: BROOKS, Carl , CHEUNG, Mui , EIDAM, Hilary, Schenck , GOODMAN, Krista, B. , HAMMOND, Marlys , HILFIKER, Mark, A. , HOANG, Tram, H. , PATTERSON, Jaclyn, R. , STOY, Patrick , YE, Guosen
IPC分类号: C07D263/52 , C07D498/00
CPC分类号: C07D413/14 , C07D417/14 , C07D419/14 , C07D495/04 , C07F9/65583
摘要: The present invention relates to spirocarbamate compounds of Formula (I) in which R1, (R2)Y, R3, R4, X and A have the meanings given in the specification. The invention further provides pharmaceutical compositions containing the compounds or pharmaceutically acceptable salts thereof and relates to their use of these compounds as TRPV4 antagonists in treating or preventing conditions associated with TRPV4 imbalance.
摘要翻译: 本发明涉及spirocarbamate式(I),其中R1,(R2)Y,R3,R4,X和A具有在说明书中给出的含义的化合物。 本发明进一步提供了含有所述化合物或药学上可接受的盐的药物组合物和涉及它们在治疗或预防与TRPV4失调相关条件下使用这些化合物作为TRPV4拮抗剂。
-
公开(公告)号:EP2721016B1
公开(公告)日:2016-04-06
申请号:EP12814591.9
申请日:2012-06-15
发明人: BROOKS, Carl , CHEUNG, Mui , EIDAM, Hilary, Schenck , GOODMAN, Krista, B. , HAMMOND, Marlys , HILFIKER, Mark, A. , HOANG, Tram, H. , PATTERSON, Jaclyn, R. , STOY, Patrick , YE, Guosen
IPC分类号: C07D263/52 , C07D498/00 , C07D419/14
CPC分类号: C07D413/14 , C07D417/14 , C07D419/14 , C07D495/04 , C07F9/65583
-
公开(公告)号:EP3121177B1
公开(公告)日:2018-08-01
申请号:EP16162808.6
申请日:2012-06-15
发明人: BROOKS, Carl , CHEUNG, Mui , EIDAM, Hilary, Schenck , GOODMAN, Krista, B , HAMMOND, Marlys , HILFIKER, Mark, A , HOANG, Tram, H , PATTERSON, Jaclyn, R , STOY, Patrick , YE, Guosen
IPC分类号: C07D413/14 , C07D417/14 , C07D419/14 , C07D495/04 , A61K31/422 , A61P9/00 , A61P11/00
CPC分类号: C07D413/14 , C07D417/14 , C07D419/14 , C07D495/04 , C07F9/65583
摘要: A combination comprising a compound of Formula (I): or a pharmaceutically acceptable salt thereof; and one or more other therapeutic agents, selected from the group consisting of endothelin receptor antagonists, angiotensin converting enzyme (ACE) inhibitors, angiotension II receptor antagonists, vasopeptidase inhibitors, vasopressin receptor modulators, diuretics, digoxin, beta blocker, aldosterone antagonists, iontropes, NSAIDS, nitric oxide donors, calcium channel modulators, muscarinic antagonists, steroidal anti-inflammatory drugs, bronchodilators, anti-histamines, leukotriene antagonist, HMG-CoA reductase inhibitors, dual non-selective ²-adrenoceptor and ± 1 -adrenoceptor antagonists, type-5 phosphodiesterase inhibitors, and renin inhibitors.
-
公开(公告)号:EP3121177A1
公开(公告)日:2017-01-25
申请号:EP16162808.6
申请日:2012-06-15
发明人: BROOKS, Carl , CHEUNG, Mui , EIDAM, Hilary, Schenck , GOODMAN, Krista, B , HAMMOND, Marlys , HILFIKER, Mark, A , HOANG, Tram, H , PATTERSON, Jaclyn, R , STOY, Patrick , YE, Guosen
IPC分类号: C07D413/14 , C07D417/14 , C07D419/14 , C07D495/04 , A61K31/422 , A61P9/00 , A61P11/00
CPC分类号: C07D413/14 , C07D417/14 , C07D419/14 , C07D495/04 , C07F9/65583
摘要: A combination comprising a compound of Formula (I):
or a pharmaceutically acceptable salt thereof;
and one or more other therapeutic agents, selected from the group consisting of endothelin receptor antagonists, angiotensin converting enzyme (ACE) inhibitors, angiotension II receptor antagonists, vasopeptidase inhibitors, vasopressin receptor modulators, diuretics, digoxin, beta blocker, aldosterone antagonists, iontropes, NSAIDS, nitric oxide donors, calcium channel modulators, muscarinic antagonists, steroidal anti-inflammatory drugs, bronchodilators, anti-histamines, leukotriene antagonist, HMG-CoA reductase inhibitors, dual non-selective β-adrenoceptor and α 1 -adrenoceptor antagonists, type-5 phosphodiesterase inhibitors, and renin inhibitors.摘要翻译: 包含式(I)化合物或其药学上可接受的盐的组合: 和一种或多种选自内皮素受体拮抗剂,血管紧张素转换酶(ACE)抑制剂,血管紧张素II受体拮抗剂,血管肽酶抑制剂,加压素受体调节剂,利尿剂,地高辛,β阻断剂,醛固酮拮抗剂,离子转运体, NSAIDS,一氧化氮供体,钙通道调节剂,毒蕈碱拮抗剂,甾体抗炎药,支气管扩张剂,抗组胺药,白三烯拮抗剂,HMG-CoA还原酶抑制剂,双重非选择性肾上腺素受体和±1-肾上腺素能受体拮抗剂, 5磷酸二酯酶抑制剂和肾素抑制剂。
-
公开(公告)号:EP2720546B1
公开(公告)日:2016-04-06
申请号:EP12800913.1
申请日:2012-06-15
发明人: BROOKS, Carl , CHEUNG, Mui , EIDAM, Hilary, Schenck , GOODMAN, Krista, B. , HAMMOND, Marlys , HILFIKER, Mark, A. , PATTERSON, Jaclyn, R. , STOY, Patrick , YE, Guosen
IPC分类号: A61K31/422 , C07D413/08 , C07D413/14 , A61P9/04
CPC分类号: C07D413/14 , C07D263/52 , C07D413/06 , C07D413/08
-
公开(公告)号:EP2720546A1
公开(公告)日:2014-04-23
申请号:EP12800913.1
申请日:2012-06-15
发明人: BROOKS, Carl , CHEUNG, Mui , EIDAM, Hilary, Schenck , GOODMAN, Krista, B. , HAMMOND, Marlys , HILFIKER, Mark, A. , PATTERSON, Jaclyn, R. , STOY, Patrick , YE, Guosen
IPC分类号: A01N43/52 , A61K31/415
CPC分类号: C07D413/14 , C07D263/52 , C07D413/06 , C07D413/08
摘要: The present invention relates to spirocarbamate analogs, pharmaceutical compositions containing them and their use as TRPV4 antagonists.
-
-
-
-
-